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Abstract
Stromal cell-derived factor 1 (SDF-1/CXCL12/PBSF) plays important roles in the biological and physiological functions of
haematopoietic and mesenchymal stem cells. This chemokine regulates the formation of multiple organ systems during
embryogenesis. However, its roles in skeletal development remain unclear. Here we investigated the roles of SDF-1 in
chondrocyte differentiation. We demonstrated that SDF-1 protein was expressed at pre-hypertrophic and hypertrophic
chondrocytes in the newly formed endochondral callus of rib fracture as well as in the growth plate of normal mouse tibia
by immunohistochemical analysis. Using SDF-1
2/2 mouse embryo, we histologically showed that the total length of the
whole humeri of SDF-1
2/2 mice was significantly shorter than that of wild-type mice, which was contributed mainly by
shorter hypertrophic and calcified zones in SDF-1
2/2 mice. Actin cytoskeleton of hypertrophic chondrocytes in SDF-1
2/2
mouse humeri showed less F-actin and rounder shape than that of wild-type mice. Primary chondrocytes from SDF-1
2/2
mice showed the enhanced formation of philopodia and loss of F-actin. The administration of SDF-1 to primary
chondrocytes of wild-type mice and SDF-1
2/2 mice promoted the formation of actin stress fibers. Organ culture of
embryonic metatarsals from SDF-1
2/2 mice showed the growth delay, which was recovered by an exogenous
administration of SDF-1. mRNA expression of type X collagen in metatarsals and in primary chondrocytes of SDF-1
2/2
mouse embryo was down-regulated while the administration of SDF-1 to metatarsals recovered. These data suggests that
SDF-1 regulates the actin organization and stimulates bone growth by mediating chondrocyte hypertrophy.
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Introduction
Endochondral ossification is an essential process for skeletal
development [1]. During skeletogenesis, mesenchymal cells
aggregate at the sites where skeletal elements will eventually be
formed, and they differentiate into chondrocytic lineage and
proliferate. The cartilage templates are composed of nonhyper-
trophic (resting and proliferating) and hypertrophic chondrocytes
as well as vast amounts of extracellular matrix produced by
chondrocytes [1]. Chondrocyte hypertrophy is a unique step in
chondrocyte differentiation, in which the cells become bigger and
rather transparent, and is a mandatory event allowing calcifica-
tion, vascularization, osteoblast differentiation, and remodeling
into bone to occur [2].
A number of secreted or intracellular polypeptides cooperatively
regulate the transition of chondrocyte hypertrophy. PTH-related
peptide, Indian hedgehog, fibroblast growth factors, SRY (sex
determining region Y)-box 9 (Sox9) and Wnt proteins are
reportedly essential factors for chondrocyte hypertrophy [3–8].
However, much less is known about the intracellular events, such
as cytoskeletal reorganization that can allow the cell size and shape
to change.
Stromal cell-derived factor-1 (SDF-1)/pre-B cell growth-stimu-
lating factor belongs to CXC subfamily of chemokines as CXCL12
[9,10]. SDF-1 signals through a G-protein-coupled receptor, C-X-
C chemokine receptor 4 (CXCR4) [10,11] and, CXCR7 [12,13],
and critical roles of SDF-1/CXCR4 in hematopoietic stem cells
(HSCs) have been extensively reported.
During the last decade, accumulating data have supported an
emerging hypothesis that SDF-1/CXCR4 also plays pivotal roles
in the biological and physiological functions of mesenchymal stem
cells (MSCs) [14,15]. SDF-1 is up-regulated at sites of injuries and
serves as a potent chemoattractant to recruit circulating or residing
CXCR4-expressing MSCs which are necessary for a tissue-specific
organ repair or regeneration in liver [16], heart [17,18], brain
[19], kidney [20], and skin [21]. We have recently demonstrated
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37163that SDF-1 recruited MSCs to bone repairing sites in the acute
phase of endochondral bone repair [22]. However, little is known
on roles of SDF-1/CXCR4 signal on the bone growth and the
endochondral bone formation.
In the process of chondrogenesis, chondrocytes change cell
shape from a fibroblastoid to a round or polygonal morphology,
which is called as hypertrophic conversion [23], a unique and
crucial step in chondrocyte differentiation. The molecular
mechanisms responsible for this cell shape change are largely
unknown, but the actin cytoskeleton presumably plays important
roles in this context. The only intracellular signaling known to
associate with the actin reorganization during chondrocyte
differentiation is RhoA/ROCK [24–26]. The reports on RhoA/
ROCK suggest that the changes in morphology have important
roles in chondrocyte differentiation. On the other hand, SDF-1
induces cytoskeleton rearrangements in homing and migration of
hematopoietic cells through Phosphoinositide 3-kinase/Akt and
RhoA/ROCK signaling [27,28], which can lead to an assumption
of the important roles of SDF-1 on the shape and size changes of
chondrocytes. This assumption, however, remains to be largely
investigated.
We herein demonstrated that SDF-1 is crucial for endochondral
bone development. The embryonic humeri of SDF-1
2/2 mice
were shorter than those of wild-type mice, especially prominent in
the hypertrophic zone. The actin cytoskeleton of SDF-1
2/2
chondrocytes in the humeri and in monolayer culture was
disturbed. With cultured metatarsal explants of SDF-1
2/2mice,
the lack of SDF-1 impaired the development of metatarsals and
chondrocyte hypertrophy, and the addition of SDF-1 reversed the
impairments. Our results strongly suggest that SDF-1 regulates
actin polymerization and stimulates bone growth by mediating
chondrocyte hypertrophy.
Results
Distribution of SDF-1 in the Growth Plate and the
Endochondral Callus
To evaluate potential roles of SDF-1 in endochondral bone
formation, we analyzed the distribution of SDF-1 in the tibial
growth plates from 4-week-old wild-type mice and newly formed
endochondral callus of rib fracture model at day 10 by
immunohistochemistry. SDF-1 was expressed at prehypertrophic
and hypertrophic chondrocytes both in the growth plate
(Figure 1A) and in the endochondral callus (Figure 1B),
suggesting important roles of SDF-1 on the transition from
prehypertrophic to hypertrophic chondrocytes in endochondral
bone formation.
Delayed Growth and Reduced Size of the Hypertrophic
Zone of SDF-1
2/2 Mouse Humeri
To investigate the effect of SDF-1 in endochondral bone
formation, we next evaluated the phenotypic differences between
SDF-1
2/2 and wild-type mice. The humeri were resected from
embryos at E13.5, E14.5, E15.5, and E16.5 (n=4 at each point),
and processed in paraffin sections (Figure 2A). The lengths of the
total humeri and the ratios of proliferating, hypertrophic, and
calcified zones were measured (Figure 2B). The total length of the
whole humerus of SDF-1
2/2 mice was shorter than that of wild-
type mice in E14.5, E15.5, and E16.5 by 17.9%, 24.7%, and
6.8%, respectively, with statistical significances. To examine which
zone contributed to the total length difference, we evaluated the
proliferating, hypertrophic, and calcified zones of the humeri as
the percentages against the total length. The ratio of hypertrophic
zone was significantly smaller in SDF-1
2/2 mice than in wild-type
mice at E14.5 and E15.5 by 21.2% and 31.0%, respectively. The
ratio of calcified zone was also smaller in SDF-1
2/2 mice than in
wild-type mice at E14.5 and E15.5 by 45.0% and 36.0%,
respectively, with statistical significances. The most marked
difference was found at E15.5, especially in the hypertrophic
zone, while no significant differences were observed in any zones
at E13.5. No significant difference was found in cell proliferation
rates between SDF-1
2/2 and wild-type mice based on 5-Bromo-29
deoxy-uridine (Brd-U) staining (Figure S1). These results
demonstrated the absence of SDF-1 mainly affects the growth of
the hypertrophic zone rather than the proliferating zone.
Absence of SDF-1 Impairs Cytoskeleton of Hypertrophic
Chondrocytes
SDF-1 signaling leads to cytoskeleton rearrangements and
integrin activation in hematopoietic cells [27]. Chondrocytes
change their shape drastically from a fibroblastoid to a round
shape during chondrogenesis. The reorganization of the actin
cytoskeleton is also demonstrated to be important in hypertrophic
transition of chondrocytes [24]. To determine whether SDF-1
affects the reorganization of the actin cytoskeleton and cellular
morphology, we stained the frozen sections of the humeri from
SDF-1
2/2 and wild-type mouse embryos (E15.5) with Rhoda-
mine-Phalloidin. No clear difference between SDF-1
2/2 and wild-
type hypertrophic chondrocytes was detected in the HE staining
(data not shown) and in the differentiation interference image
(Figure 3A). But interestingly, the Rhodamine-Phalloidin staining
showed that the hypertrophic chondrocytes in SDF-1
2/2 mice
was rounder than wild-type mice. Quantification of F-actin
revealed that F-actin content of hypertrophic chondrocytes in
SDF-1
2/2 mice was significantly lower than wild-type mice
(P,0.05, Figure 3B). Next, to measure the ellipticity of
chondrocytes, we calculated the ratio of a short axis to the long
axis (1/ellipticity). The reciprocal of ellipticity was significantly
higher in SDF-1
2/2 chondrocytes than in wild-type chondrocytes
(P,0.05, Figure 3C), which support the roundness of SDF-1
2/2
hypertrophic chondrocytes. These tendencies were also observed
in hypertrophic chondrocytes of SDF-1
2/2 metatarsals (data not
shown).
SDF-1 Controls the Actin Organization of Primary
Chondrocytes
Based on the results described above, we investigated whether
SDF-1 regulates the actin cytoskeleton of the chondrocytes, F-actin
of primary chondrocytes were stained with Rhodamine-Phalloidin.
Untreated chondrocytes from wild-type mice had a defined
cortical rim, minimal stress fibers, and a polyhedral shape
(Figure 4). With treatment of SDF-1 (100 ng/ml), the chondro-
cytes changed their shape into contractile rounded shape in a time-
dependent manner. Incubation of the chondrocytes for 10 m with
SDF-1 showed the actin stress fiber formation.
Next, wild-type primary chondrocytes were treated with SDF-1,
or SDF-1 and CXCR4 specific antagonist, TF14016 [29]
(100 mM), or pertussis toxin (PTX, 100 ng/ml) for 60 m
(Figure 5A). Treatment with SDF-1 to primary chondrocytes
resulted in contractile rounded cells with thick cortical rim of actin
filaments. The chondrocytes treated with SDF-1 and TF14016
showed the similar morphology to untreated chondrocytes. Cells
treated with SDF-1 and PTX showed slight induction of actin
stress fibers. In quantitation of the F-actin in the Rhodamine-
Phalloidin-stained cells, the F-actin content treated with SDF-1 for
60 m was significantly higher than the actin density of the
SDF-1 on Cytoskeleton and Chondrocyte Hypertrophy
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SDF-1+TF14016 (Figure 5B).
Then we investigated the actin filaments of primary chondro-
cytes from SDF-1
2/2 mice. Those chondrocytes clearly showed
the enhanced formation of philopodia and the lost of F-actin
through 7-day culture, compared with those of wild-type mice.
The administration of recombinant SDF-1 to the chondrocytes of
SDF-1
2/2 mice inhibited the philopodia formation and the loss of
F-actin. The cortical rim and shape of SDF-1
2/2 chondrocytes
with recombinant SDF-1 was similar to that of wild-type
chondrocytes (Figure 5C). Quantification of F-actin revealed
that actin density of SDF-1
2/2 chondrocytes was lower than that
of wild-type chondrocytes and of SDF-1
2/2 chondrocytes
incubated with recombinant SDF-1 (P,0.01, P,0.05, respective-
ly) (Figure 5D). These results suggest that SDF-1/CXCR4
signaling strongly affects the reorganization of the actin cytoskel-
eton and the cellular morphology in primary chondrocytes.
Deficit of SDF-1/CXCR4 Signaling Delays the Growth of
Metatarsals in Organ Culture
The phenotypic changes of SDF-1
2/2 mice exclusively
occurred from E14.5 to E16.5. This period corresponds to the
time of the vascular invasion, which indicates that molecular and/
or cellular factors from circulation compensate for the lack of
SDF-1. To verify the independent effects of endogenous SDF-1 in
pre-vascularized bone, we used the primary metatarsal explant
culture system. The metatarsal bones were harvested from wild-
type mice at E15.5, cultured for 7 days, and the total length was
measured at day 1, 3, 5 and 7 (Figure 6). We first confirmed that
no vascular formation was observed in metatarsal bones at this
stage by histology (data not shown).
As shown in Figure 6A, the metatarsal bones of wild-type mice
kept up growing during the whole culture period and the ratio of
the total length growth reached to 134% at day 7. The growth
delayed at every time point in SDF-1+/2 and SDF-1
2/2 mice,
and the ratios of the total length growth remained 128% and
121% at day 7, respectively. At the end of this culture assay, the
total length of SDF-1
2/2 metatarsal bones was 9.7% shorter than
wild-type metatarsals with statistical significance, indicating the
functional effect of endogenous SDF-1 in the normal bone growth.
Then, to investigate whether SDF-1 can restore the perturbed
growth of SDF-1
2/2 metatarsal bones, 100 ng/ml of SDF-1 was
added to the primary metatarsal culture system. The treatment of
SDF-1 significantly regained the ratio of the total length growth of
SDF-1
2/2 metatarsals from 124% to 137% at day 7, which was
the similar growth rate of wild-type metatarsals. Interestingly,
during this assay, we observed calcified zones, verified by von
Kossa staining, were found in 80.0%, 69.2%, and 16.7% of wild-
type, SDF-1+/2, and SDF-1
2/2 metatarsals, respectively at day 7
(Figures 6B, C), indicating that the delayed differentiation of
hypertrophic chondrocytes affects the calcification of those cells in
SDF-1
2/2 mice, which was consistent with the phenotype of the
SDF-1
2/2 humerus (Figure 2).
These results strongly support the notion that self-produced
SDF-1 is crucial for endochondral bone development at the pre-
vascularized stage.
Figure 1. SDF-1 protein was expressed at the prehypertrophic and hypertrophic zones. The growth plate of 4-week-old mouse tibia (A)
and endochondral callus of rib fracture (B) were stained with hematoxylin and eosin (HE), or immunohistochemically stained with antiSDF-1 antibody
or IgG (control). Boxed areas in the panel are shown in a higher magnification (6200) in the right panels. The result is representative of three separate
experiments; Scale bar, 200 mm.
doi:10.1371/journal.pone.0037163.g001
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Expression
To examine the effect of SDF-1 to the phenotypical expression
of type X collagen (Col X), and Sox9, metatarsal bones from
E15.5 wild-type and SDF-1
2/2 mouse embryos were cultured
with or without SDF-1 for 3 or 7 days, and total RNAs were
extracted and quantified by real-time PCR.
The expression of Col X mRNA increased from day 3 to day
7 in untreated wild-type metatarsals (Figure 6D), which
demonstrated the normal growth of the explant culture. The
expression of Col X mRNA decreased significantly at day 7 in
untreated SDF-1
2/2 metatarsals. The administration of recom-
binant SDF-1 to SDF-1
2/2 metatarsals recovered the expres-
sion of Col X. There was no statistically significant difference in
Sox9 expression.
Furthermore, primary chondrocytes isolated from wild-type and
SDF-1
2/2 mice were cultured for 3 weeks in chondrogenic
medium supplemented with insulin to induce chondrocyte
differentiation. Chondrocytes from SDF-1
2/2 mice showed
decreased Col X expression compared with that from wild-type
mice (Figure 6E). The expression of Sox9 showed no statistically
significant difference.
Figure 2. Growth of the embryonic humeri of SDF-1
2/2 mice delays. A: The embryonic humeri of wild-type (WT) and SDF-1
2/2 (KO) mice.
Specimenswereprocessedtoparaffin-embeddedsectionsandstainedwithhematoxylin,eosin(lowerpanels)andalcianblue(upperpanels).B:Lengthof
thehumeri.Thetotallengthofthehumeriandtheratiosoftheproliferating,thehypertrophic,orthecalcifiedzoneineachdaywerecalculatedasdescribed
in Methodssection.Valuesarethemeanandstandarddeviationof morethanthreeindependentexperiments; *, P,0.05;Scalebar,300 mm.
doi:10.1371/journal.pone.0037163.g002
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SDF-1/CXCR4 plays important roles in the biological and
physiological functions of MSCs [14,15], serving as a potent
chemoattractant to recruit circulating or residing CXCR4-
expressing MSCs to injured organs [16–21], including the
fracture site of bones [22]. SDF-1 also plays crucial roles in the
formation of multiple organ systems during embryogenesis [30–
32], and it has been shown to associate with several diseases
involving the skeleton, including rheumatoid arthritis and
cancers that metastasize to the bone [33,34]. In the present
study we showed, for the first time, the promotion of
chondrocyte hypertrophy with SDF-1 and contribution of
SDF-1 to the actin reorganization, which had been shown to
be important for chondrocyte differentiation.
During the endochondral bone development, SDF-1 is
expressed at the growth plate, but the precise localization of
SDF-1 in the growth plate is controversial. A previous study
showed that SDF-1 was expressed in the central region of the
proliferating zone of the growth plate at E14.5 and it was
expressed in the periosteum and central region of the proliferating
zone at E16.5 [35]. On the other hand, another study showed that
SDF-1 was expressed in the area adjacent to the hypertrophic zone
of the growth plate [36]. Immunohistochemical analysis of the
current study revealed that SDF-1 protein was expressed in
hypertrophic chondrocytes of the growth plates of the tibia and the
fracture callus (Figure 1) as well as the hypertrophic zone of
mouse embryos (data not shown). These data suggest that SDF-1
has important, physiological roles in the hypertrophic zone during
the endochondral bone formation even after birth.
Figure 3. Cytoskeleton of hypertrophic chondrocytes in the humeri. A: Frozen sections of the humeri isolated from SDF-1
2/2 (KO), and wild-
type (WT) mice at E15.5, were fixed with paraformaldehyde and stained with Rhodamine-Phalloidin for actin filaments and SYBR Green for nuclei. Left
panel, Rhodamine-Phalloidin; middle panel, merge of Rhodamine-Phalloidin and SYBR Green; right panel, differentiation interference image.
Representative fields are shown. B: The intensity of actin filament staining (F-actin) was quantified with Image J software. Values were normalized to
F-actin of WT chondrocytes. C: The ratios of the short axis to the long axis (1/Ellipticity) in chondrocytes were calculated with Image J. Values are the
mean and s.e.m. of more than three separate experiments; *, P,0.05; Scale bar, 10 mm.
doi:10.1371/journal.pone.0037163.g003
SDF-1 on Cytoskeleton and Chondrocyte Hypertrophy
PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e37163SDF-1 is involved in the migration of hematopoietic progenitors
and morphogenesis of leukocytes [37]. In the processes, SDF-1
induces morphological changes in adherent leukocytes and the
acquisition of a bipolar shape with front leading edges [38,39], by
stimulating the actin polymerization in a Rac and Cdc42-
dependent fashion [38], and activating the small GTPases that
control the actin cytoskeleton [40]. On the other hand, the actin
cytoskeleton plays important roles in cellular homeostasis,
proliferation and differentiation [41,42]. Even in the hypertrophic
transition during chondrocyte differentiation, chondrocytes
change the cell shape from a fibroblastoid to a round or polygonal
morphology [23] and, as an upstream regulator of cytoskeletal
dynamics, RhoA/ROCK signaling was shown to associate with
chondrocyte hypertrophy [43]. In this study, incubation of wild-
type and SDF-1
2/2 chondrocytes with SDF-1 changed the cell
shape with an increase of F-actin density (Figure 4). In
accordance with this fact, actin cytoskeletons of wild-type and
SDF-1
2/2 hypertrophic chondrocytes in the humeri were
different in the amount and the shape (Figure 3). These results
suggest that SDF-1 signaling affects the reorganization of the actin
cytoskeleton and the maintenance of the cellular morphology.
Phenotypic changes of SDF-1
2/2 hypertrophic chondrocytes of
the humeri were mostly observed from E14.5 to E15.5, and the
significant difference was lost at E16.5 (Figure 2). As we observed
the vascularization of the humeri at E15.5 with the expression of
SDF-1, we assume that the shortness of the humeri of SDF-1
2/2
mice is compensated by the effects of circulating factors from
blood after neovascularization occurs. To exclude the effect of the
vascularization of the humeri, the organ culture of metatarsal
bones was performed, and we found that the bone growth was
disturbed by lack of SDF-1, and that the discretion was rescued by
the administration of SDF-1. These results suggest that SDF-1 is
crucial in chondrocyte differentiation at the prevascularized stage,
and the functions of SDF-1 in chondrocyte differentiation are
totally apart from roles on the recruitment of MSCs nor HSCs.
The bone growth is driven primarily by the rate of production
of hypertrophic chondrocytes from proliferating chondrocytes
[44]. In the metatarsal explant culture, lack of SDF-1 resulted in
the decreased expression of Col X with disturbance of the bone
growth (Figures 6A, D). This fact suggests SDF-1 signaling is
important for the hypertrophic conversion of proliferating
chondrocytes. Interestingly, the appearance of the calcified zones
was delayed in the explant culture of SDF-1
2/2 mice
(Figures 5B, C). Since the hypertrophic conversion is a
prerequisite of calcification of chondrocytes, SDF-1 is suggestively
crucial on the hypertrophic conversion and the subsequent
calcification of chondrocytes. Indeed, the delayed calcification
was also found in the SDF-1
2/2 humeri (Figure 2A), and the
disturbed hypertrophic conversion led to the shortness of calcified
zones as well as that of the hypertrophic zones in SDF-1
2/2
mouse embryos (Figure 2B). Furthermore, the stimulation of
SDF-1 to SDF-1
2/2 metatarsals increased the expression of Col X
mRNA (Figure 6D). Since SDF-1 is expressed at prehypertrophic
and hypertrophic chondrocytes (Figure 1) with CXCR4 expres-
sion being the strongest in the hypertophic chondrocytes [36], the
effects of SDF-1 on chondrocyte differentiation may have occurred
mainly in the prehypertrophic and hypertrophic zones as
enhancement of chondrocyte hypertrophy.
Figure 4. SDF-1 simulates actin assembly and stress fiber formation in a time-dependent manner. Primary chondrocytes from wild-type
mice were treated with SDF-1 (100 ng/ml) as indicated. Cells were then fixed with paraformaldehyde and stained with Rhodamine-Phalloidin for actin
filaments and 49,6-diamidino-2-phenylindole for nuclei; Scale bar, 20 mm.
doi:10.1371/journal.pone.0037163.g004
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Firstly this study does not show the intracellular signaling of
SDF-1 in chondrocyte differentiation. Figure 5A showed that
formation of actin stress fibers in untreated wild-type chondro-
cytes and chondrocytes treated with SDF-1 and TF14016 was
similar, but a slight actin stress fiber formation was observed in
cells treated with SDF-1 and PTX. Since PTX inactivates Gi,
actin stress fiber formation with SDF-1 and PTX may also have
resulted from the increase of F-actin and contraction of
actomyosin through G12/13. Actin stress fiber formation for
the hypertrophic transition by SDF-1 may strongly depend on
Gi in addition to G12/13. This result is compatible with a
previous report that RhoA/ROCK signaling, downstream of
G12/13, inhibited hypertrophic differentiation [43]. SDF-1
signal transduction pathway in chondrocytes is still elusive and
remains to be investigated in the future.
Figure 5. SDF-1/CXCR4 pathway controls actin cytoskeleton. A: Treatment with SDF-1 increased the actin filament density in primary
chondrocytes. Primary chondrocytes from wild-type mice were treated with SDF-1 (100 ng/ml), or SDF-1 and CXCR4 specific antagonist, TF14016
(100 mM) or pertussis toxin (PTX, 100 ng/ml) for 60 m and stained with Rhodamine-Phalloidin. B: The F-actin content in chondrocytes was analyzed
with Image J software. All values were normalized to F-actin of chondrocytes treated with conditioned medium only. C: Actin cytoskeleton of primary
chondrocyte from SDF-1
2/2 (KO), and wild-type (WT) mice. D: The F-actin content in chondrocytes was quantified with Image J software. All values
were normalized to the F-actin of wild-type chondrocyte. Values are the mean and s.e.m. of more than three separate experiments; *, P,0.05,
**,P,0.05; Scale bar, 20 mm.
doi:10.1371/journal.pone.0037163.g005
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elucidate the association of SDF-1 signaling with other signaling
molecules regulating the hypertrophic conversion of chondrocytes.
RhoA/ROCK signaling, the only signaling shown to associate
with actin organization during chondrogenesis, suppresses Sox9
expression [24]. Sox9 mRNA expression, however, did not show
any significant difference between wild-type and SDF-1
2/2
metatarsals and primary chondrocytes in monolayer in this study
Figure 6. Lack of SDF-1 delays the growth metatarsals in organ culture. A: The metatarsal bones were harvested from SDF-1
2/2 (KO), SDF-
1+/2 (hetero), and wild-type (WT) mice at E15.5, cultured for 7 days, and the total length was measured at day 1, 3, 5, and 7. The length of metatarsal
bones was calculated by day 1 as controls. B: Calcified spots (arrows) were counted in KO and WT metatarsals at day 1 and 7. C: Metatarsal bones
were stained with hematoxylin and eosin (upper panel), or von Kossa (lower panel); Scale bar, 200 mm. D: The expression levels of type X collagen
(Col X) and Sox9 of cultured metatarsal bones from E15.5 WT and KO mice at day 3 and 10 were quantified by real-time PCR. E: Primary chondrocytes
isolated from WT and KO mice were cultured for 3 weeks in chondrogenic medium supplemented with insulin. The expression levels of Col X and
Sox9 were quantified by real-time PCR. Values are the mean and s.e.m. of more than three independent experiments; *, P,0.05.
doi:10.1371/journal.pone.0037163.g006
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sion in chondrocytic differentiation and the bone growth without
the involvement of Sox9, but this assumption requires further
investigations.
In addition, the influence of genetic background of SDF-1
2/2
mice cannot completely be removed. As about half of SDF-1
2/2
mice start to die after E16.5 for unknown reasons, contamination
of the dying embryos can affect the results. These dying embryos
are easily distinguishable by their relatively small size and dark red
color and we did not use these embryos for the experiments.
However, there is still a possibility of the contamination. One of
the solutions for this issue is the use of conditional knock-out mice.
As there is no report showing mice that express Cre recombinase
specifically in SDF-1-expressing prehypertrophic and/or hyper-
trophic chondrocytes, this issue should be pursued in the near
future.
In conclusion, we investigated the role of SDF-1 in chondrocyte
differentiation and revealed that SDF-1 stimulates bone growth by
mediating chondrocyte hypertrophy and regulates actin polymer-
ization.
Materials and Methods
Reagents
Recombinant mouse CXCL12/SDF-1a was purchased from
R&D Systems (Minneapolis, MN). Pertussis toxin (PTX) was
purchased from Sigma-Aldrich (St. Louis, MO).
Mice
All animal studies were conducted in accordance with principles
by Kyoto University Committee of Animal Resources, based on
International Guiding Principles for Biomedical Research Involv-
ing Animals. All procedures for this study were approved by Kyoto
University Committee of Animal Resources (Permit Number:
MedKyo 11260). The generation of SDF-1
2/2 mice has been
previously described [45]. Heterozygotes were maintained and
backcrossed more than 10 times with C57BL/6NCrSlc mice.
Homozygous mutant embryos were present at the expected
Mendelian ratios until E15.5, and about half of the SDF-1
2/2
embryos were dead at E18.5. The embryos that die within the
uteri were slightly small in dark red color, and these were not used
for the experiments.
Mouse Rib Fracture Model
Mouse rib fracture model was created using 6-week-old wild-
type (C57BL/6NCrSlc) mice as previously described [46]. The
mice were sacrificed at day 10 for histological analysis.
Histological Analysis and Measurement of the Ratios of
Proliferating and Hypertrophic Chondrocytes
Specimens were processed to paraffin-embedded sections with a
thickness of 5–7 mm, and stained with hematoxylin, eosin and
alcian blue. The areas of proliferating and hypertrophic cartilages
were measured by computer tracing as previously described [47].
Immunohistochemical analysis was performed to detect SDF-1
protein as previously described [22].
Visualization of Cytoskeleton in Hypertrophic
Chondrocytes of the Humeri
The humeri of embryonic day 15.5 (E15.5) were isolated from
wild-type embryos or crosses of SDF-1
+/2 mice. Samples were
frozen in O.C.T. Compound (Sakura Finetek Japan, Tokyo,
Japan). Tissues were cryosectioned at 12 mm, and briefly airdried.
Sections were fixed with 4% paraformaldehyde for 20 m, followed
by two washes in phosphate-buffered saline (PBS). The mem-
branes were permeabilized with 0.5% Triton X-100/PBS solution
for 20 m, and incubated in the dark for 2 h with 100 nM
Rhodamine-Phalloidin (Cytoskelton, Denver, CO) and 0.01%
SYBR Green I nucleic acid gel stain (Life Technologies, Carlsbad,
CA). Images were taken with Nicon P-Eclipse C1 confocal
microscopy equipped with objective lens 60X/1.40 oil.
Isolation and Culture of Primary Chondrocytes
Primary chondrocytes were isolated from embryonic ribs at
E15.5 and cultured in Dulbecco’s Modified Eagle Medium, which
was regarded as post passage 0 (pp 0). When the cells became pre-
confluent, the cells were trypsinized and were passaged (pp 1). Cell
suspensions at the cell concentration of 1610*5 cells/ml were used
for actin polymerization assay. Primary chondrocytes (pp 0) were
also cultured for 3 weeks in chondrogenic medium supplemented
with insulin (10 mg/ml), transferrin (5.5 mg/ml), and sodium
selenite (5 ng/ml) (Sigma, St. Louis, MO) to induce chondrocyte
differentiation, as previously described [48].
Actin Polymerization Assay of Primary Chondrocytes
To investigate the function of SDF-1, the cells were treated with
SDF-1, TF14016, and/or PTX added to the medium for 1 m,
5 m, 10 m, 30 m, 1 h, 3 h, or 24 h. Then the cells were fixed with
4% paraformaldehyde for 10 m, and stained with 100 nM
Rhodamine-Phalloidin and 0.05% 49,6-diamidino-2-phenylindole
for 30 s or 0.01% SYBR Green according to the manufacture’s
protocol. Images were taken Olympus IX70 laser microscopy or
Nicon P-Eclipse C1 confocal microcopy, and analyzed with Image
J as described before [49].
Metatarsal Organ Culture
Three central metatarsal rudiments were isolated from each
hind limb of E15.5 embryos. Every three metatarsals from each
limb were placed into each well of a 24-well plate containing
0.5 ml of organ culture medium as previously described [50]. The
day of explant harvest was regarded as day 0 and the culture
medium was replaced at day 1, and 4. SDF-1 were applied to the
well containing the explants from the right hind limb, and the ones
from the left hind limb were treated with culture medium alone as
controls. Cultures were observed and photographed with an
Olympus SZX 12 dissecting microscope at day 1, 3, 5, and 7. The
cultured metatarsals were harvested at day 7 for histological
procedure, and at day 3 or 7 for RNA extraction.
RNA Extraction and Quantitative Real-time PCR
Total RNA from cultured metatarsal bones were snap frozen in
liquid nitrogen, homogenized, and extracted total RNA using
High Pure RNA Tissue Kit (Roche Diagnostics, Penzberg,
Germany). Total RNA from primary chondrocyte was extracted
using High Pure RNA Isolation Kit (Roche Diagnostics). The
RNA was reverse-transcribed and real-time quantitative PCR was
performed using FastStart Universal SYBR Green Master (Roche
Diagnostics) and ABI7500 (Life Technologies) according to the
manufacturer’s instructions. All of gene expression data were
normalized against glyceraldehyde-3-phosphate dehydrogenase
(GAPDH, forward primer, 59- AGGTCGGTGTGAACG-
GATTTG, and reverse primer 59- TGTAGACCATGTAGTT-
GAGGTCA). Expression patterns of Col X (forward primer, 59-
AGGCTACCTGGATCAGGCTTC, and reverse primer 59-
ACATTCTTTTCAGCCTACCTCC), and Sox9 mRNA (for-
ward primer, 59-GAGCCGGATCTGAAGAGGGA, and reverse
SDF-1 on Cytoskeleton and Chondrocyte Hypertrophy
PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e37163primer 59- GCTTGACGTGTGGCTTGTTC) were also ana-
lyzed. Standard curve was generated by serially diluted plasmids
containing PCR amplicon sequences. Plasmids were synthesized
using pTAC-1 vector (BioDynamics Laboratory, Tokyo, Japan).
Proliferation Assay
BrdU incorporation was assessed by the cell proliferation
ELISA Biotrack kit (Amersham Biosciences, Piscataway, NJ).
BrdU was administrated into the mice at E15.5 2 h before the
harvest. BrdU-positive cells were detected immunohistochemically
as previously described [22].
Statistical Analysis
Data were analyzed with Student’s t test. A p value less than
0.05 was considered statistically significant.
Supporting Information
Figure S1 BRd-U staining of embryonic humeri. A: BRd-
U staining of embryonic humeri of wild-type (WT) and SDF-1
2/2
(KO) mice. Embryonic humeri of wild-type and SDF-1
2/2 mice
were processed to paraffin-embedded sections and stained with
Brd-U. B: The percentage of positive cells for BRd-U was
calculated in WT and KO humeri.
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